rupatadine has been researched along with web 2086 in 1 studies
Studies (rupatadine) | Trials (rupatadine) | Recent Studies (post-2010) (rupatadine) | Studies (web 2086) | Trials (web 2086) | Recent Studies (post-2010) (web 2086) |
---|---|---|---|---|---|
116 | 43 | 62 | 600 | 8 | 31 |
Protein | Taxonomy | rupatadine (IC50) | web 2086 (IC50) |
---|---|---|---|
Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | 0.1093 | |
Platelet-activating factor receptor | Homo sapiens (human) | 0.1735 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balsa, D; Ferrando, R; Forn, J; GarcĂa-Rafanell, J; Giral, M; Merlos, M; Puigdemont, A; Queralt, M | 1 |
1 other study(ies) available for rupatadine and web 2086
Article | Year |
---|---|
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Topics: Administration, Oral; Animals; Azepines; Blood Pressure; Cyproheptadine; Dogs; Guinea Pigs; Histamine Antagonists; Male; Mice; Motor Activity; Platelet Activating Factor; Platelet Aggregation; Pyrilamine; Rabbits; Rats; Rats, Sprague-Dawley; Triazoles | 1997 |